Defective apoptosis underlies chemoresistance in ovarian cancer

Adv Exp Med Biol. 2008:622:197-208. doi: 10.1007/978-0-387-68969-2_16.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / physiology*
  • Apoptotic Protease-Activating Factor 1 / genetics
  • Apoptotic Protease-Activating Factor 1 / metabolism*
  • Drug Resistance, Neoplasm / physiology*
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*

Substances

  • APAF1 protein, human
  • Antineoplastic Agents
  • Apoptotic Protease-Activating Factor 1